Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-019334
Filing Date
2025-07-03
Accepted
2025-07-03 16:39:40
Documents
1
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 form4-07032025_080736.html 4  
1 form4-07032025_080736.xml 4 7690
  Complete submission text file 0001415889-25-019334.txt   9215
Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address
Levy Richard S (Reporting) CIK: 0001454983 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 251106057

Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Issuer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)